Adaptive Biotechnologies Corp Stock Price on June 14, 2021

ADPT Stock  USD 3.21  0.32  11.07%   
Below is the normalized historical share price chart for Adaptive Biotechnologies Corp extending back to June 27, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adaptive Biotechnologies stands at 3.21, as last reported on the 28th of March, with the highest price reaching 3.34 and the lowest price hitting 2.93 during the day.
IPO Date
27th of June 2019
200 Day MA
5.2386
50 Day MA
3.7676
Beta
1.268
 
Covid
If you're considering investing in Adaptive Stock, it is important to understand the factors that can impact its price. Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of standard deviation over the last 3 months. Adaptive Biotechnologies Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adaptive Biotechnologies' risk adjusted performance of (0.1), and Mean Deviation of 3.28 to double-check the risk estimate we provide.
  
At this time, Adaptive Biotechnologies' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 811.6 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 10.3 K in 2024. . At this time, Adaptive Biotechnologies' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.41 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.06) in 2024. Adaptive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1985

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsADPT

Estimated Market Risk

 3.95
  actual daily
34
66% of assets are more volatile

Expected Return

 -0.78
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average Adaptive Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adaptive Biotechnologies by adding Adaptive Biotechnologies to a well-diversified portfolio.
Price Book
1.3502
Enterprise Value Ebitda
(0.89)
Price Sales
2.4242
Shares Float
96.8 M
Wall Street Target Price
6.6

Adaptive Biotechnologies Valuation on June 14, 2021

It is possible to determine the worth of Adaptive Biotechnologies on a given historical date. On June 14, 2021 Adaptive was worth 10.91 at the beginning of the trading date compared to the closed value of 10.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adaptive Biotechnologies stock. Still, in general, we apply an absolute valuation method to find Adaptive Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adaptive Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adaptive Biotechnologies' related companies.
 Open High Low Close Volume
03/14/2022
  10.91    11.06    9.90    10.12    1,760,000  
  10.26    10.86    10.22    10.75    2,321,800  
Backtest Adaptive Biotechnologies  |  Adaptive Biotechnologies History  |  Adaptive Biotechnologies Valuation Next  
Open Value
10.91
10.12
Closing Value
22.77
Upside

Adaptive Biotechnologies Trading Date Momentum on June 14, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Adaptive Biotechnologies Fundamentals Correlations and Trends

By evaluating Adaptive Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adaptive Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adaptive financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Adaptive Biotechnologies Stock history

Adaptive Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adaptive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adaptive Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adaptive Biotechnologies stock prices may prove useful in developing a viable investing in Adaptive Biotechnologies
Last ReportedProjected for 2024
Common Stock Shares Outstanding144.4 M131.8 M
Net Loss-180.2 M-189.2 M

Adaptive Biotechnologies Quarterly Net Working Capital

322.17 Million

Adaptive Biotechnologies Stock Technical Analysis

Adaptive Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Adaptive Biotechnologies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Adaptive Biotechnologies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Adaptive Biotechnologies Period Price Range

Low
March 14, 2022
High

 10.91 

  

 10.12 

-0.79-7.24%

Adaptive Biotechnologies March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Adaptive Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adaptive Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adaptive Biotechnologies stock market strength indicators, traders can identify Adaptive Biotechnologies Corp entry and exit signals to maximize returns

Adaptive Biotechnologies Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Adaptive Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adaptive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adaptive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Adaptive Biotechnologies is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adaptive Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adaptive Biotechnologies Corp Stock. Highlighted below are key reports to facilitate an investment decision about Adaptive Biotechnologies Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Adaptive Stock analysis

When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.56)
Revenue Per Share
1.179
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.17)
Return On Equity
(0.58)
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.